business
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors?
Key takeaways
- Post-transaction value (direct ownership)
- Transaction and post-transaction values based on SEC Form 4 weighted average reported price ($11.02).
- Personalis offers genomic sequencing and data analysis services for cancer research and therapy development, including the NeXT Platform, ImmunoID Next, NeXT Liquid Biopsy, NeXT Personal, and related products.
PSNL Christopher M. Hall, Chief Executive Officer of Personalis (NASDAQ:PSNL), disclosed the direct exercise and immediate sale of 100,000 shares of Common Stock, valued at approximately $1.10 million, in a transaction reported on May 29, 2026. SEC Form 4 filing
Post-transaction value (direct ownership)
Transaction and post-transaction values based on SEC Form 4 weighted average reported price ($11.02).
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Liftoff shares rise 9.1% in debut after $437 million IPO
Investing.com
Nucor EVP John Hollatz sells $2.7m in company stock
Investing.com
Gator Capital buys $54,034 in U.S. Global Investors (GROW) shares
Fortune
Exclusive: Investors bet $40 million on Honeycomb’s no-inspection home insurance AI
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop